3753 results
Keyword Sinemet RM Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Aquipta (updated)
atogepant, Migraine Disorders
Date of authorisation: 11/08/2023,
, Authorised, Last updated: 25/08/2023
icon application/pdf h-5871-rmp_en.pdf 25/08/2023 Generic This EPAR … -
List item
Human medicine European public assessment report (EPAR): Pregabalin Sandoz GmbH
pregabalin, Anxiety Disorders; Epilepsy
Date of authorisation: 19/06/2015,
, Revision: 15, Authorised, Last updated: 13/06/2023
h-4070-rmp_summary_en.pdf … -
List item
Human medicine European public assessment report (EPAR): Pregabalin Sandoz
pregabalin, Anxiety Disorders; Neuralgia; Epilepsy
Date of authorisation: 19/06/2015,, Revision: 16, Authorised, Last updated: 13/06/2023
h-4010-rmp_summary_en.pdf … -
List item
Human medicine European public assessment report (EPAR): Saxenda
liraglutide, Obesity; Overweight
Date of authorisation: 23/03/2015, Revision: 13, Authorised, Last updated: 12/06/2023h-3780-rmp_summary_en.pdf … -
List item
Human medicine European public assessment report (EPAR): Armisarte (previously Pemetrexed Actavis)
pemetrexed diacid monohydrate, Carcinoma, Non-Small-Cell Lung; Mesothelioma
Date of authorisation: 18/01/2016, Revision: 13, Authorised, Last updated: 01/06/2023h-4109-rmpsummary_en.pdf … -
List item
Human medicine European public assessment report (EPAR): Ebilfumin
oseltamivir, Influenza, Human
Date of authorisation: 22/05/2014,, Revision: 15, Authorised, Last updated: 01/06/2023
h-3717-rmpsummary_en.pdf … the risk management plan (RMP) for EBILFUMIN 30 mg, 45 … referred to as Ebilfumin). The RMP details important risks of … -
List item
Human medicine European public assessment report (EPAR): Sancuso
granisetron, Vomiting; Cancer
Date of authorisation: 20/04/2012, Revision: 14, Authorised, Last updated: 29/03/2023icon application/pdf h-2296-rmp_summary_en.pdf 16/06/2020 29/03/2023 Generic … -
List item
Human medicine European public assessment report (EPAR): Brinavess
Vernakalant hydrochloride, Atrial Fibrillation
Date of authorisation: 01/09/2010, Revision: 16, Authorised, Last updated: 03/03/2022accordingly. Update of the RMP to version 7.0 to incorporate … a category 3 study in the RMP (PASS Protocol 6621- 049 … -
List item
Human medicine European public assessment report (EPAR): Bretaris Genuair
aclidinium bromide, Pulmonary Disease, Chronic Obstructive
Date of authorisation: 20/07/2012,, Revision: 18, Authorised, Last updated: 05/01/2023
icon application/pdf h-2706-rmp_summary_en.pdf 02/07/2021 02/07/2021 Generic … -
List item
Human medicine European public assessment report (EPAR): Scenesse
afamelanotide, Protoporphyria, Erythropoietic
Date of authorisation: 22/12/2014,, 
, 
, Revision: 9, Authorised, Last updated: 04/11/2022
h-2548-rmpsummary_en.pdf … -
List item
National expert: Mario Miguel Coelho da Silva Rosa, National Authority Of Medicines And Health Products (updated)
- Declaration of interests - 40.15 KB | PDF
- Curriculum Vitae - 67.7 KB | PDF
and Levodopa/Carbidopa (Sinemet).Clin drug Invest 9 (6): 363_366 … -
List item
Human medicine European public assessment report (EPAR): Erleada (updated)
apalutamide, Prostatic Neoplasms
Date of authorisation: 14/01/2019,, Revision: 10, Authorised, Last updated: 22/09/2023
-
List item
Human medicine European public assessment report (EPAR): Alunbrig (updated)
brigatinib, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 22/11/2018,, Revision: 9, Authorised, Last updated: 22/09/2023
-
List item
Human medicine European public assessment report (EPAR): LysaKare (updated)
L-arginine hydrochloride, L-lysine hydrochloride, Radiation Injuries
Date of authorisation: 25/07/2019, Revision: 4, Authorised, Last updated: 22/09/2023 -
List item
Human medicine European public assessment report (EPAR): Opfolda (updated)
miglustat, Glycogen Storage Disease Type II
Date of authorisation: 26/06/2023, Revision: 1, Authorised, Last updated: 22/09/2023 -
List item
Human medicine European public assessment report (EPAR): Adcirca (previously Tadalafil Lilly) (updated)
tadalafil, Hypertension, Pulmonary
Date of authorisation: 01/10/2008, Revision: 17, Authorised, Last updated: 22/09/2023 -
List item
Human medicine European public assessment report (EPAR): Fortacin (updated)
lidocaine, prilocaine, Sexual Dysfunction, Physiological
Date of authorisation: 15/11/2013, Revision: 12, Authorised, Last updated: 22/09/2023icon application/pdf h-2693-rmp_summary_en.pdf 19/10/2020 Generic This EPAR … -
List item
Human medicine European public assessment report (EPAR): Semglee (updated)
insulin glargine, Diabetes Mellitus
Date of authorisation: 23/03/2018,
, Revision: 9, Authorised, Last updated: 22/09/2023
icon application/pdf h-4280-rmp_summary_en.pdf 22/09/2023 Generic This EPAR … -
List item
Human medicine European public assessment report (EPAR): Veyvondi (updated)
vonicog alfa, von Willebrand Diseases
Date of authorisation: 31/08/2018,, Revision: 8, Authorised, Last updated: 19/09/2023
-
List item
Human medicine European public assessment report (EPAR): Steglujan (updated)
ertugliflozin l-pyroglutamic acid, sitagliptin phosphate monohydrate, Diabetes Mellitus, Type 2
Date of authorisation: 23/03/2018, Revision: 11, Authorised, Last updated: 19/09/2023 -
List item
Human medicine European public assessment report (EPAR): Litfulo (updated)
ritlecitinib tosilate, Alopecia Areata
Date of authorisation: 15/09/2023,, Authorised, Last updated: 18/09/2023
-
List item
Human medicine European public assessment report (EPAR): Apealea (updated)
paclitaxel, Ovarian Neoplasms
Date of authorisation: 20/11/2018, Revision: 7, Authorised, Last updated: 18/09/2023 -
List item
Human medicine European public assessment report (EPAR): Lumeblue (previously known as Methylthioninium chloride Cosmo) (updated)
methylthioninium chloride, Colorectal Neoplasms; Colonoscopy
Date of authorisation: 19/08/2020, Revision: 3, Authorised, Last updated: 18/09/2023 -
List item
Human medicine European public assessment report (EPAR): GHRYVELIN (previously Macimorelin Aeterna Zentaris) (updated)
macimorelin acetate, Diagnostic Techniques, Endocrine
Date of authorisation: 11/01/2019,, Revision: 3, Authorised, Last updated: 18/09/2023
-
List item
Human medicine European public assessment report (EPAR): Ranivisio (updated)
ranibizumab, Wet Macular Degeneration; Macular Edema; Diabetic Retinopathy; Diabetes Complications
Date of authorisation: 25/08/2022,, , Revision: 3, Authorised, Last updated: 18/09/2023